Saint-Herblain (France), March 3, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming ...

Saint-Herblain (France), March 3, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...

The CDC is look­ing in­to a hand­ful of hos­pi­tal­iza­tion cas­es af­ter peo­ple got Ix­chiq, Val­ne­va’s vac­cine for chikun­gun­ya, ac­cord­ing to a no­tice post­ed to the … ...

This prediction ended on 23.02.25 with a price of €7.40. With a performance of 68.95% the BUY prediction by MoneySwing29 was a big success. MoneySwing29 has 50% into this prediction ...

More information is available at www.valneva.com. This press release contains certain forward-looking statements relating to the business of Valneva, including with respect to business partnerships ...